This review uncovers several mechanisms through which lncRNAs influence tamoxifen resistance in breast cancer including enhanced ER signaling, suppression of apoptosis, autophagy, exosome-mediated transfer, epigenetic alterations, epithelial-to-mesenchymal transition and acting as ceRNA. The gene discussed is ESR1; the disease is breast cancer.